title: In Reply.
authors.affiliation: Department of Obstetrics and Gynecology, Zagazig University School of Medicine, Zagazig, Egypt Department of Obstetrics and Gynecology, Cairo University Faculty of Medicine, El Manial, Cairo, Egypt Department of Obstetrics and Gynecology, Zagazig University School of Medicine, Zagazig, Egypt.
authors.forename: Eman
authors.initials: E
authors.lastname: Elgindy
authors.forename: Magdy
authors.initials: M
authors.lastname: Mostafa
authors.forename: Hoda
authors.initials: H
authors.lastname: Sibai
authors.forename: Amany
authors.initials: A
authors.lastname: Abdelghani
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D059247:Fertility Preservation / Q000379:methods*; D007987:Gonadotropin-Releasing Hormone / Q000627:therapeutic use*; D006801:Humans; D011247:Pregnancy; D016649:Primary Ovarian Insufficiency / Q000517:prevention & control*; D020011:Protective Agents / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D020011:Protective Agents; D007987:Gonadotropin-Releasing Hormone